ProfileGDS4718 / 217002_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 54% 57% 70% 55% 53% 52% 54% 57% 55% 58% 58% 61% 55% 52% 54% 54% 55% 53% 48% 49% 62% 52% 54% 52% 56% 52% 51% 48% 52% 54% 54% 53% 55% 52% 52% 51% 53% 56% 58% 54% 52% 54% 51% 53% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.7204354
GSM549102patient 115, normal, homogenized [OPG study]5.9330657
GSM549104patient 119, normal, homogenized [OPG study]6.9548370
GSM549108patient 138, normal, homogenized [OPG study]5.8404355
GSM549119patient 077, normal, homogenized [OPG study]5.7148653
GSM549133patient 032, cancer, homogenized [OPG study]5.6112552
GSM549139patient 042, cancer, homogenized [OPG study]5.7366554
GSM549099patient 107, normal, homogenized [OPG study]5.9162757
GSM549109patient 139, normal, homogenized [OPG study]5.8355155
GSM549110patient 046, normal, homogenized [OPG study]6.0152358
GSM549114patient 063, normal, homogenized [OPG study]5.9195358
GSM549122patient 082, normal, homogenized [OPG study]6.192661
GSM549134patient 033, cancer, homogenized [OPG study]5.7729155
GSM549136patient 036, cancer, homogenized [OPG study]5.5989552
GSM549140patient 044, cancer, homogenized [OPG study]5.7352554
GSM549111patient 047, normal, homogenized [OPG study]5.7461854
GSM549113patient 057, normal, homogenized [OPG study]5.7367955
GSM549132patient 031, cancer, homogenized [OPG study]5.6696653
GSM549137patient 038, cancer, homogenized [OPG study]5.3827948
GSM549142patient 047, cancer, homogenized [OPG study]5.5852549
GSM549100patient 110, normal, homogenized [OPG study]6.2155962
GSM549107patient 135, normal, homogenized [OPG study]5.6271152
GSM549115patient 068, normal, homogenized [OPG study]5.7232654
GSM549116patient 072, normal, homogenized [OPG study]5.586152
GSM549120patient 078, normal, homogenized [OPG study]5.8780956
GSM549131patient 030, cancer, homogenized [OPG study]5.5994752
GSM549118patient 074, normal, homogenized [OPG study]5.588551
GSM549129patient 027, cancer, homogenized [OPG study]5.4375248
GSM549123patient 088, normal, homogenized [OPG study]5.5919852
GSM549124patient 006, cancer, homogenized [OPG study]5.7584154
GSM549126patient 015, cancer, homogenized [OPG study]5.7160854
GSM549128patient 025, cancer, homogenized [OPG study]5.6541253
GSM549103patient 117, normal, homogenized [OPG study]5.8703655
GSM549117patient 073, normal, homogenized [OPG study]5.5929352
GSM549138patient 041, cancer, homogenized [OPG study]5.6142652
GSM549141patient 045, cancer, homogenized [OPG study]5.51451
GSM549130patient 028, cancer, homogenized [OPG study]5.6855753
GSM549101patient 111, normal, homogenized [OPG study]5.9128856
GSM549105patient 128, normal, homogenized [OPG study]6.0319358
GSM549106patient 134, normal, homogenized [OPG study]5.7087954
GSM549112patient 048, normal, homogenized [OPG study]5.6413452
GSM549125patient 011, cancer, homogenized [OPG study]5.7457554
GSM549127patient 024, cancer, homogenized [OPG study]5.5851451
GSM549135patient 035, cancer, homogenized [OPG study]5.6360753